1)MHCC97-H cellMHCC97-H细胞
1.Method shRNA sequences,two selected from HBx gene integrated in the genome of human hepatocellular carcinoma cell line MHCC97-H cells named X169 and X220 and another control sequence named MOCK,were synthesized and cloned into pGenesil-Ⅰvector.目的构建靶向整合于人肝癌MHCC97-H细胞乙型肝炎病毒x基因(HBxgene)基因的shRNA真核载体。
英文短句/例句
1.Effects of KAI1 Gene on Growth and Invasion of MHCC97-H Human Hepatocellular Carcinoam Cells;KAI1基因对肝癌MHCC97-H细胞生长及侵袭能力的影响
2.Effects and Mechanisms of KAI1 Gene on Invasion and Metastasis of MHCC97-H Human Hepatocellular Carcinoma Cells;KAI1基因对MHCC97-H肝癌细胞侵袭转移的影响及机制
3.Study on the Expression of Focal Adhesion Kinase in Hepatocellular Carcinoma and Its Role in MHCC-97H Cell;焦点粘附激酶在肝癌中表达及其对人肝癌细胞MHCC97-H作用的研究
4.Study on Mechanism of Action of Thalidomide for Hepatic Cell Cancer in Nude Mice Implanted with MHCC97-H Cells;沙利度胺在肝癌细胞MHCC97-H荷瘤裸鼠中的作用机制的实验学研究
5.Isolation and Property of Hepatocarcinoma Stem Cells from MHCC97 Cell Lines;MHCC97中肝癌干细胞的分离及其特性
6.Reversion of multi-drug resistance (MDR) in human MHCC97 cells by RNA small interference(siRNA)siRNA干扰技术逆转MHCC97肝癌细胞多药耐药性
7.INHIBITIVE EFFECT OF ANGIOGENESIS INHIBITORS ON VASCULOGENIC MIMICRY IN HUMAN HEPATOCELLULAR CARCINOMA CELL LINE MHCC97-H IN VITROTNP-470对MHCC97-H体外血管生成拟态的抑制作用
8.Effect about the Synthetic Inhibitor of Urokinase Plasminogen Activator to the Invasion and Metastasis of Hepatoma Carcinoma Cell: MHCC97-C;uPA合成抑制剂阿米洛利对人肝癌细胞系MHCC97侵袭转移能力的作用研究
9.Proteomics Analysis Reveals Insight into the Mechanism of H-Ras-Mediated Transformation;H-Ras介导细胞转化的蛋白质组学分析
10.Morphology and Fiber Connection of Cells in Layers A-H of Chick Optic Tectum雏鸡视顶盖A-H层细胞形态与纤维联系
11.PTEN-mediated resistance to tyrosine kinase inhibitors in lung cancer cell lines H-157 and H-1355H-157与H-1355肺癌细胞株PTEN表达与TKI耐药关系初步实验观察
12.Study on derivation of H/RS cell and its clonal relation with the backgroun lymphocytes in classical Hodgkin s lymphoma;cHL H/RS细胞来源及与周围背景淋巴细胞克隆相关性研究
13.The Morphological Study of Peritoneal Mesothelial Cell and Lymphatic Stomata during Metastasis of HepA-H CellsHepA-H肝癌细胞腹膜转移过程中间皮细胞和淋巴孔的形态学研究
14.Research on Inhibition Activity of h-PNAS-4 Against Ovarian Cancer Cell Lines in Vitro;h-PNAS-4抑制人卵巢癌细胞系体外增殖的研究
15.Experiment Study of mic2/CD99 Gene Transforms the H/RS Cells of L428 Cell Line into Lymphoma Cell;mic2/CD99上调诱导L428 H/RS细胞转型的实验研究
16.Effect of Extracts of Trichosanthes Root Tubers on HepA-H Cells and HeLa Cells;栝楼根提取物对肿瘤细胞HepA-H和HeLa的作用研究
17.Experimental Study on Removing Endotoxin and Cytokines with HB-H-7 Resin AdsorptionHB-H-7树脂吸附内毒素和细胞因子的实验研究
18.Sdosodine Hydrochlorida on Gene Expressions of c-myc, H-ras and hTRT of HeLa CellsSBHL对HeLa细胞c-myc,H-ras和hTRT基因表达的研究
相关短句/例句
MHCC97-HMHCC97-H细胞株
3)MHCC97 cellMHCC97细胞
1.Methods:The expression of CXCR4 mRNA and protein was examined by RT-PCR and Western blotting in 21 specimens of hepatocellular carcinoma tissues,MHCC97 cells,HUVECs,and .目的:研究趋化因子受体CXCR4在肝细胞癌组织、肝癌MHCC97细胞、人脐带血管内皮细胞(HUVEC)中的表达,同时检测肝癌患者腹水中CXCR4的配体CXCL12的含量,为进一步探讨CXCR4在肝癌细胞转移中的作用奠定基础。
4)highly metastatic HCC cell line MHCC97高转移肝癌细胞MHCC97
5)H/RS cellH/RS细胞
1.Study on protein expression of H/RS cell and it s background lymphocytes in classical Hodgkin s lymphoma;Chl H/RS细胞与背景细胞蛋白表达的相关性
2.Conclusion The H/RS cells of classical Hodgkin′s lymphoma appear to be derived from a later .结论经典型霍奇金淋巴瘤的H/RS细胞起源于生发中心后期分化的B细胞,它是一种活化的B细胞。
3.Objective To investigate the lineage of H/RS cell in classical Hodgkin lymphoma.目的 探讨经典型Hodgkin淋巴瘤H/RS细胞的细胞属性。
6)HepA-H cellsHepA-H细胞
1.The anti-tumor effect of trichosanthin on HepA-H cells and HeLa cells;天花粉蛋白对HepA-H细胞和HeLa细胞抑癌活性研究
延伸阅读
白间素, 欣吉尔, T细胞生长因子 ,白细胞介素-2药物名称：白细胞介素-2英文名：Interleukin-2别名： 白间素, 欣吉尔, T细胞生长因子 ,白细胞介素-2外文名：Interleukin-2 ,IL-2适应症： 白介素－２是一个分子量为１４５００的糖蛋白，它刺激已被特异性抗原或致丝裂因数启动的Ｔ细胞增殖。重组白介素－２可用于临床研究。主要用于肾癌、黑色素瘤和非何杰金淋巴瘤有效（Ｒｏｓｓｅｎｂｅｒｇ）。ＬＡＫ细胞代表１个有单核巨噬细胞，Ｂ和Ｔ淋巴细胞特征的异原的细胞体。这些ＬＡＫ细胞似乎对癌细胞有特异作用。此外，ＬＡＫ细胞（不象Ｔ细胞）介导杀伤不受ＭＨＣ的约束。 注意事项： 1.胃肠道反应有恶心、呕吐、腹泻等。 2.少数病人有发热不适、呼吸困难、嗜伊红细胞增多、贫血、水潴留（毛细管漏出综合征）、瘙痒、胆红素和肌酐水平短暂增高、鼻出血、舌炎、口干、精神状态改变、精神混乱、定向力障碍和精神变态。 3.血小板减少、红斑或皮疹、低血压、尿少、脱发和心肌梗塞等。 规格： 粉针剂:1000u,10000u, 10万u, 100万u. 类别：免疫增强剂||其他抗肿瘤药及辅助治疗药
